The specific targeting of CXCR3 may possibly be more effective for the therapy of chronic cardiac inflammation in combination with approaches enhancing Treg numbers and activity, which are generally reduced in cardiovascular diseases. Here, CXCR3 is linked to cardiovascular disorder.